Health officials in California are investigating whether a native coronovirus strain can be partially blamed for the state’s rise in infections.
According to the Los Angeles Times, scientists stumbled upon the new strain, looking for signs of a highly contagious version originating in the United Kingdom before making its way to the US.
During that discovery, researchers termed B.1.426, a new strain found, which is thought to be responsible for the rapid increase of infection during the holiday season in California, where more than 3.1 million cases have been reported and 36,790 cases have been reported. People have been killed.
The new strain is also highly contagious and is spreading faster than any other variant in California.
‘While the B.1.1.7 strain may play an important role in increasing COVID rates in the UK and Europe, there are still no reports for the current spike of cases in Los Angeles and California, which began in early November Thi 2020, ‘researchers at Cedars-Sinai Medical Center wrote in their findings.
Health officials in California are investigating whether a native coronovirus strain, called B-1.426, may be partially to blame for the state’s rise in infection. The strain contains five mutations, CAL.20C (red bubble), which has been found rapidly in California
According to the researchers, the CAL.20C strain was barely identifiable in October, but by December it made up 24 percent of the 4,500 virgin samples.
The graphic shows the rapid growth of infections in California between late December to November. Researchers have considered this to be a domestic strain of coronovirus, blaming the increase
In California, more than 3.1 million cases have been reported and 36,790 people have died. More than 18,000 people died in less than three months in the state
“We report the existence of a novel strain CAL.20C that is currently increasing in numbers in Southern California,” he said.
The B.1.426 strain was initially discovered in July, but was not seen again until three months later.
According to research, the CAL.20C strain was barely identifiable in October, but by December it made up 24 percent of the 4,500 virgin samples.
In a separate study, researchers found that 25 percent of viral samples from Northern California were of the same type between late November and December, according to the LA Times.
A lab specialist from UC San Francisco, Dr. Charles Chiu told the newspaper, “There was a domestic version under our noses.
Chiu said that if he had not been exploring the tension in Britain, he could have ‘missed it at all levels’.
According to the Cedars-Sinai team, the B.426 strain has five mutations, including the L452R mutation, which replaces the virus’ spike proteins. The spike protein is what the virus uses to infiltrate human cells.
The new strain is believed to have been partially responsible for doubling his death in California in less than three months.
However, how much of the new role played in the increase is still unclear due to the presence of other factors, including holiday celebrations and those who disregard CDC guidance.
To determine the role of B.1.426 in enhancement, investigators are trying to figure out what it is capable of.
In a separate study, researchers found that between late November and December, 25 percent of viral samples from Northern California were of the same type. A doctor examines a patient with COVID-19 in Los Angeles
Researchers told the LA Times that they would focus on its proliferation capacity and its ability to bypass masks, drugs and vaccines, which are being used as tools to stop the spread.
Meanwhile, the Center for Disease Control and Prevention (CDC) is advancing its efforts to track coronovirus mutations to ensure that COVID-19 vaccines and treatment stay ahead of new variants of the disease until collective immunity is achieved . .
Dr. Rochelle Wallensky explained the implications of the rapidly evolving virus during a Fox News Sunday interview
More than 25 million Americans have been infected with the virus and more than 418,000 deaths occurred exactly one year after the first US case of COVID-19 was documented.
Valensky, who took over as CDC director last Wednesday, the day President Joe Biden was sworn in, also said that the biggest immediate culprit for sluggish vaccine delivery is poor supply from inventory confusion inherited from the Trump administration .
Fox News reported on Sunday that we do not know this fact till date, five days in this administration, and weeks in planning, how much vaccine we have.
Biden’s transition team was largely excluded from the government’s vaccine rollout deliberations for weeks after his election as the then-President Donald Trump refused to give up, and the incoming administration to prepare the government Was allowed to access the required information.
More than 25 million cases of the virus have occurred in the US since the pandemic began last year
Ron Clann, chief of staff, said in a separate interview on NBC’s Meet the Press that the plan to distribute vaccines, especially beyond nursing homes and hospitals, was ‘really present when we came to the White House’ Were not.
Wallensky said he is confident that the government will soon solve the supply questions, and will move to a dramatic expansion of vaccine production and distribution by the end of March.
However, uncertainty over immediate supply will hamper efforts at the state and local levels of how many vaccination sites, personnel and appointments are planned in the meantime, to meet short-term shortages.
Vaccination has become ever more important with the recent emergence of more coronovirus variants believed to be more infectious, and in the case of a strain first found in Britain, possibly more fatal.
“We are now talking about monitoring these and studying these,” said Valenski, adding that the CDC was collaborating with the National Institutes of Health, the Food and Drug Administration, and even the Pentagon.
He said, ‘The impact of these variants on the vaccine as well as our medical science’ is to be monitored, as it continues to spread while spreading the virus.
As long as vaccines can provide immunity to the ‘herd’ in the population, wearing masks and social disturbances is important to reduce the amount of ‘viruses’ that are roaming, and therefore, reduce the amount of variants that occur there. Do, ‘Valensky said.
Although British officials warned on Friday that the so-called UK version of coronovirus, already detected in at least 20 US states, was associated with higher levels of mortality, scientists have said that current vaccines are still against Seem effective.
They worry, however, that a more infectious South African version may reduce the efficacy of current vaccines and demonstrate resistance to three antibody therapies developed to treat COVID-19 patients.
The similarities between the South African version and others identified in Brazil may make the Brazilian variety opposed to antibody treatment.
‘We are in the race against these variants,’ Vivek Murthy nominated by Biden to become the next American Surgeon General on ABC’s This Week program on Sunday.
The country’s leading infectious disease specialist, Dr. Anthony Fauci said that at the end of December he was optimistic that the US could gain enough collective immunity to COVID to achieve ‘some semblance of normality’ by the fall of 2021.
But Murthy said that achieving herd immunity was ‘an ambitious goal’ before a new school started in September.
Nevertheless, Murthy suggested that the government could surpass Biden’s objective, with the aim of getting 100 million vaccinations in the first 100 days of his presidency, telling ABC News; It is not a roof. ‘
Fauci separately stated in CBS News’ Face the Nation, the 100-million-shot goal includes people who have received both injections of two-dose vaccines and who have received only the first jab.